Eyegate Pharmaceuticals (EYEG) is Initiated by Chardan Capital Markets to Buy, Price Target at $6

Eyegate Pharmaceuticals (EYEG) is Initiated by Chardan Capital Markets to Buy according to the research report released to the investors. The brokerage firm has set the Price Target of the shares at $6. The shares recommendation by the Brokerage Firm was released on Dec-23-2015.